6 Hematology Headlines You Missed in January 2026

January 2026 brought a wave of clinically meaningful updates across hematology, spanning new clinical practice guidelines, regulatory approvals, and late-stage pipeline momentum in both malignant and nonmalignant disease. Organizations including the American Society of Hematology (ASH) and Kidney Disease: Improving Global Outcomes (KDIGO) released updated guidance aimed at improving diagnostic accuracy and supportive care, while the US Food and Drug Administration (FDA) expanded treatment options for rare bleeding and thrombotic disorders.